Kataovp
19+Portfolio
Invest in early to mid‑clinical stage life science companies in Israel, providing hands‑on management and early‑stage cooperation with prominent partners to maximize returns and improve health.
Where they invest
Geography
Portfolio footprintHover a country to explore
- United States of America
- 36.8%
- Israel
- 21.1%
- Mexico
- 5.3%
- India
- 5.3%
Darker countries represent a larger share of the portfolio.
What they back
Industries
- Artificial Intelligence
- 42.1%
- Healthcare Technology
- 36.8%
- Biotechnology
- 26.3%
- Data & Analytics
- 26.3%
- Hardware
- 21.1%
- Medical Devices
- 21.1%
% of all portfolio companies. Industry categories can overlap.
Stages
Stage indicator
No stages listed
Fund details
Funds
Katao VP General LP
Vintage 2021 • $100M